 Pinnacle Associates Ltd. lowered its holdings in shares of  Xylem Inc. (NYSE:XYL – Free Report) by 17.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 314,381 shares of the industrial products company’s stock after selling 68,185 shares during the quarter. Pinnacle Associates Ltd.’s holdings in Xylem were worth $40,668,000 at the end of the most recent quarter.
Pinnacle Associates Ltd. lowered its holdings in shares of  Xylem Inc. (NYSE:XYL – Free Report) by 17.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 314,381 shares of the industrial products company’s stock after selling 68,185 shares during the quarter. Pinnacle Associates Ltd.’s holdings in Xylem were worth $40,668,000 at the end of the most recent quarter. 
A number of other hedge funds and other institutional investors have also bought and sold shares of XYL. Maseco LLP bought a new position in shares of Xylem during the 2nd quarter worth approximately $31,000. ST Germain D J Co. Inc. grew its stake in shares of Xylem by 950.0% during the 2nd quarter. ST Germain D J Co. Inc. now owns 252 shares of the industrial products company’s stock worth $33,000 after acquiring an additional 228 shares in the last quarter. Signature Resources Capital Management LLC bought a new position in shares of Xylem during the 2nd quarter worth approximately $39,000. Headlands Technologies LLC grew its stake in shares of Xylem by 90.6% during the 1st quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company’s stock worth $36,000 after acquiring an additional 145 shares in the last quarter. Finally, Zions Bancorporation National Association UT bought a new position in shares of Xylem during the 1st quarter worth approximately $40,000. Institutional investors and hedge funds own 87.96% of the company’s stock.
Xylem Trading Down 0.9%
Shares of Xylem stock opened at $151.52 on Friday. The business has a fifty day simple moving average of $144.59 and a two-hundred day simple moving average of $133.92. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a market capitalization of $36.89 billion, a price-to-earnings ratio of 38.95, a P/E/G ratio of 2.50 and a beta of 1.13. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.43.
Xylem Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Thursday, August 28th were issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 1.1%. The ex-dividend date of this dividend was Thursday, August 28th. Xylem’s dividend payout ratio is currently 41.13%.
Insider Buying and Selling
In other Xylem news, CAO Geri-Michelle Mcshane sold 1,000 shares of the company’s stock in a transaction on Friday, September 5th. The stock was sold at an average price of $139.96, for a total value of $139,960.00. Following the transaction, the chief accounting officer directly owned 2,957 shares of the company’s stock, valued at $413,861.72. This represents a 25.27% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 0.27% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several equities analysts have recently weighed in on XYL shares. UBS Group raised their price target on shares of Xylem from $164.00 to $168.00 and gave the stock a “buy” rating in a research note on Tuesday, August 5th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Xylem in a research note on Wednesday, October 8th. Citigroup boosted their price target on Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a research report on Wednesday. TD Cowen boosted their price target on Xylem from $125.00 to $130.00 and gave the stock a “hold” rating in a research report on Tuesday, August 26th. Finally, Royal Bank Of Canada boosted their price target on Xylem from $169.00 to $176.00 and gave the stock an “outperform” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $166.20.
View Our Latest Stock Analysis on Xylem
About Xylem
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Further Reading
- Five stocks we like better than Xylem
- Where Do I Find 52-Week Highs and Lows?
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- Large Cap Stock Definition and How to Invest
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						 
						